Home / Resources / On-Demand Webinar / Managing Pre-clinical Study Data as a Strategic Asset
Managing Pre-clinical Study Data as a Strategic Asset

On-Demand Webinar

In this webinar, David Lowis, D. Phil. of Certara, makes the case for adopting a solution that allows immediate access, visualization and analysis of pre-clinical data for optimized decision making, while leveraging the FDA mandated CDISC-SEND data standard. Joining Dr. Lowis will be Stuart Horowitz, PhD, President of Institutional Services at WIRB-Copernicus Group. Dr. Horowitz will frame this challenge of pre-clinical data access/analysis with an eye toward accelerated regulatory approval. Hear how a holistic approach can deliver business value and competitive advantage and provide rapid insights that let you anticipate and respond to regulatory questions and accelerate promising programs or stop unproductive ones more quickly so you can get your product to market faster.

In this webinar, David Lowis, D. Phil. of Certara, made the case for adopting a solution that allows immediate access, visualization and analysis of pre-clinical data for optimized decision making, while leveraging the FDA mandated CDISC-SEND data standard. Hear how a holistic approach can provide rapid insights that let you anticipate and respond to regulatory questions and accelerate promising programs or stop unproductive ones more quickly so you can get your product to market faster.

Back to top